EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Use of Recombinant Chikungunya Virus expressing Nanoluciferase to Identify Chondrocytes as Target Cells in an Immunocompetent Mouse Model

Vincent Legros iD, Essia Belarbi iD, Patricia Jeannin, Virginie Geolier iD, Beate M Kümmerer iD, David Hardy iD, Philippe Desprès, Antoine Gessain, Pierre Roques iD, Pierre-Emmanuel Ceccaldi, Valérie Choumet iD

The Journal of Infectious Diseases · 14.08.2025 · 232 (2) · e223-e233

DOI: 10.1093/infdis/jiaf232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 16.06.2025. Verfasst von Vincent Legros und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unité Epidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, Université Paris Cité, UMR CNRS 3569, Paris, France. Hauptthemen laut MEDLINE: Chikungunya virus, Chondrocytes, Chikungunya Fever, Luciferases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Region Ile de France, Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV) induces predominantly symptomatic infections, marked by fever, myalgia, rash and polyarthralgia that can last for up to 3 years after infection. Understanding the pathophysiology of CHIKV in the joints is challenging due to limited access to biological samples. Using a reporter virus expressing Nanoluciferase in a mouse model allowed us to monitor viral replication in real-time during acute and postacute phases. We showed viral replication in chondrocyte containing tissue in the metatarsi joints and confirmed with ex vivo analyses viral replication in leg bones and articular cartilages with histological evidence of focal erosive lesions and periarticular inflammation. Moreover, human chondrocytes prove susceptible to CHIKV infection, exhibiting viral production and bioluminescence activity. CHIKV induced apoptosis, the up-regulation of markers associated with cartilage remodeling and altered cytokine production. Our study provides insights into the ability of CHIKV to infect articular cartilages, shedding light on the mechanisms of alphaviral arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya virusChondrocytesChikungunya FeverLuciferasesAnimalsMiceDisease Models, AnimalHumansVirus ReplicationCartilage, Articular

Stichwörter der Autor:innen

in vivo imagingarthritisbioluminescencechikungunyachondrocyte

Substanzen

Luciferases

Autor:innen und Institutionen

  • Unité Epidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, Université Paris Cité, UMR CNRS 3569, Paris, France.
  • Unité Recherche et Expertise Environnement et Risques Infectieux, Institut Pasteur, Université Paris Cité, Paris, France.
  • Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.
  • Institute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.
  • German Centre for Infection Research, Partner Site Bonn-Cologne, Bonn, Germany.
  • Plate-Forme d'Histopathologie, Institut Pasteur, Université Paris Cité, Paris, France.

ORCID-Profile: Vincent Legros, Essia Belarbi, Virginie Geolier, Beate M Kümmerer, David Hardy, Pierre Roques, Valérie Choumet

Förderung

  • Region Ile de France
  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale

Zitieren

APA

Legros, V., Belarbi, E., Jeannin, P., Geolier, V., Kümmerer, B. M., Hardy, D., Desprès, P., Gessain, A., Roques, P., Ceccaldi, P. E., & Choumet, V. (2025). Use of Recombinant Chikungunya Virus expressing Nanoluciferase to Identify Chondrocytes as Target Cells in an Immunocompetent Mouse Model. The Journal of Infectious Diseases, 232(2), e223-e233. https://doi.org/10.1093/infdis/jiaf232

Vancouver

Legros V, Belarbi E, Jeannin P, Geolier V, Kümmerer BM, Hardy D, et al. Use of Recombinant Chikungunya Virus expressing Nanoluciferase to Identify Chondrocytes as Target Cells in an Immunocompetent Mouse Model. The Journal of Infectious Diseases. 2025;232(2):e223-e233. doi:10.1093/infdis/jiaf232

BibTeX
@article{Legros2025,
  author = {Legros, Vincent and Belarbi, Essia and Jeannin, Patricia and Geolier, Virginie and Kümmerer, Beate M and Hardy, David and Desprès, Philippe and Gessain, Antoine and Roques, Pierre and Ceccaldi, Pierre-Emmanuel and Choumet, Valérie},
  title = {Use of Recombinant Chikungunya Virus expressing Nanoluciferase to Identify Chondrocytes as Target Cells in an Immunocompetent Mouse Model},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {232},
  number = {2},
  pages = {e223--e233},
  doi = {10.1093/infdis/jiaf232}
}
Kostenlos starten →